Pagaya looks deeply undervalued following a 44.6% selloff despite robust growth. Click for more about PGY stock.

Eli Lilly execs believe the first oral version of their blockbuster GLP-1 drugs won't cannibalize sales of the injectables ...

Novo Nordisk stock slid after weak 2026 guidance and rising GLP-1 competition from Eli Lilly. Is NVO a buy on the dip?

Blend Labs Inc trading in (NYSE:BLND) recently drew attention following a sharp month-over-month decline, extending a longer ...

Food and beverage company PepsiCo (NASDAQ:PEP) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales ...

Asian markets traded mixed, while the stock market ended lower overnight after a sell-off in technology stocks. Sentiment in the domestic market remains upbeat after the announcement of the India-US ...

The global nutraceuticals market, valued at approximately USD 416 billion in 2026, is projected to grow at a CAGR of around 9% over the next five years.Key factors driving this growth include ...

ONEOK stock is a "Buy" given its organic growth, synergy gains, and potential upside. Here's what investors need to know about OKE.

Saber Interactive announced the port management simulation game, Docked, will launch for the PlayStation 5, Xbox Series X|S, and PC via Steam and Epic Games Store on March [...] ...

W.W. Grainger, Inc. (NYSE:GWW) Q4 2025 Earnings Call Transcript February 3, 2026 W.W. Grainger, Inc. misses on earnings expectations. Reported EPS is $9.44 EPS, expectations were $9.46. Operator: ...

You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. [The stock market looks ...

The dour mood around tech has turned a spotlight on chipmaker AMD's after-hours earnings report, which could provide the best ...